ProfileGDS5678 / 1439710_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 53% 47% 49% 48% 49% 50% 63% 49% 50% 50% 50% 50% 51% 50% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3391353
GSM967853U87-EV human glioblastoma xenograft - Control 23.0913147
GSM967854U87-EV human glioblastoma xenograft - Control 33.1799249
GSM967855U87-EV human glioblastoma xenograft - Control 43.0929348
GSM967856U87-EV human glioblastoma xenograft - Control 53.1300849
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.285350
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.8226263
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1712349
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1641250
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1830750
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.205850
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1624250
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2239651
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.187850